1 From the Cardiology Branch, and the Clinic of Surgery, National Heart Institute, Bethesda, Maryland.
The relation between cardiac norepinephrine concentration and the functional state of the myocardium was studied in left ventricular papillary muscles removed from patients with congestive heart failure at the time of mitral valve replacement. Myocardial function was assessed by determining the maximum isometric active tension that the papillary muscle could develop in an in vitro system, and by measuring the increase in active tension in response to the norepinephrine-releasing sympathomimetic amine, tyramine. The norepinephrine concentration averaged 0.36 µg./Gm. in 17 muscles. In eight of these a response to tyramine was observed with a 21-per cent increase in active tension, and the norepinephrine concentrations averaged 0.53 µg./Gm.; in the other six muscles tested with tyramine no positive inotropic response was observed, and the norepinephrine concentration was significantly lower, averaging 0.16 µg./Gm. The maximum active tension in 17 muscles averaged 1.78 Gm./mm.2, and a significant positive correlation between the maximum tension and the norepinephrine concentration of the individual muscles was observed. In the eight muscles responding to tyramine, the maximum tension observed, 2.34 Gm./mm.2, was significantly greater than that observed in the six muscles unresponsive to tyramine, 0.64 Gm./mm.2 It is concluded that norepinephrine depletion appears to be associated with defective myocardial function although no causal relationship between these two abnormalities has been established.
© 1966 American Heart Association, Inc.
Norepinephrine Stores and Contractile Force of Papillary Muscle from the Failing Human Heart
This article has been cited by other articles:
![]() |
S. Ohshima, S. Isobe, H. Izawa, M. Nanasato, A. Ando, A. Yamada, K. Yamada, T. S. Kato, K. Obata, A. Noda, et al. Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2061 - 2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Foody, M. H. Farrell, and H. M. Krumholz {beta}-Blocker Therapy in Heart Failure: Scientific Review JAMA, February 20, 2002; 287(7): 883 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Braunwald Congestive heart failure: a half century perspective Eur. Heart J., May 2, 2001; 22(10): 825 - 836. [PDF] |
||||
![]() |
G. A. LANGER, A. J. BRADY, K. I. SHINE, and J. A. SOPIS Cardiac Disease and Its Treatment--SomePhysiological Correlations Ann Intern Med, May 1, 1970; 72(5): 715 - 727. [Abstract] [PDF] |
||||
![]() |
T. N. James, E. S. Bear, K. F. Lang, E. W. Green, and H. H. Winkler Adrenergic Mechanisms in the Sinus Node Arch Intern Med, March 1, 1970; 125(3): 512 - 547. [Abstract] [PDF] |
||||
![]() |
A. M. WEISSLER The Heart in Heart Failure Ann Intern Med, November 1, 1968; 69(5): 929 - 940. [Abstract] [PDF] |
||||
![]() |
E. BRAUNWALD, C. A. CHIDSEY, P. E. POOL, E. H. SONNENBLICK, J. ROSS JR., D. T. MASON, J. F. SPANN, and J. W. COVELL Congestive Heart Failure: Biochemical and Physiological Considerations * Combined Clinical Staff Conference at the National Institutes of Health Ann Intern Med, April 1, 1966; 64(4): 904 - 941. [Abstract] [PDF] |
||||
![]() |
J.-F. Wang, J. Zhang, J.-Y. Min, M. F. Sullivan, C. S. Crumpacker, W. H. Abelmann, and J. P. Morgan Cocaine enhances myocarditis induced by encephalomyocarditis virus in murine model Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H956 - H963. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1966 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |